The device is designed for use in areas with slightly thicker skin and is intended for applications such as non-surgical hair restoration.
NanoPass Technologies Ltd plans to introduce MicronJet 800 at IMCAS World 2026, scheduled for Jan 29–31, in Paris.
The addition expands the company’s MicronJet product line, which currently includes MicronJet 600, a 0.6 mm intradermal delivery device with a flow rate equivalent to a 30-gauge needle. According to the company, MicronJet 600 and MicronJet 800 are intended to serve complementary roles across a range of aesthetic and dermatological applications and formulations.
MicronJet 800 is designed for use in areas with slightly thicker skin and is intended for applications such as non-surgical hair restoration, where controlled intradermal delivery is required. The device is also positioned for use in treatments involving the jawline and cheeks, hyperhidrosis, and scar revision, where accurate placement is important, according to the company.
The 0.8 mm intradermal device is approved for substances indicated for intradermal administration and is optimized for medium-to-high viscosity formulations. NanoPass says MicronJet 800 offers a flow rate equivalent to a 27-gauge needle while maintaining consistent intradermal depth. The device connects to standard Luer-lock or Luer-slip syringes smaller than 3 mL and can be integrated into clinical workflows following brief training.
Unlike conventional stainless-steel needles, MicronJet devices are manufactured using silicon-crystal delivery pyramids produced with semiconductor-grade MEMS technology. The company says this design supports resistance to blunting during procedures involving multiple injections and contributes to consistent penetration. According to NanoPass, the MicronJet platform has been evaluated in more than 70 clinical studies spanning vaccines, therapeutics, and aesthetic applications.
“The main advantage of MicronJet in scalp therapy is that it is virtually pain-free, a clear and compelling benefit for both patients and practitioners. MicronJet ensures effective intradermal placement while maintaining comfort, making it an ideal solution for hair restoration treatments,” says Dr Alberto Diaspro, maxillofacial plastic surgeon from Italy, in a release.
Across the MicronJet portfolio, the devices are used for intradermal delivery in applications including skin rejuvenation, scar treatment, axillary hyperhidrosis, stretch marks, pigmentation, lip hydration, local anesthesia, and non-surgical hair restoration. The system is compatible with substances such as non-cross-linked hyaluronic acid, skin boosters, polynucleotides, microtoxin, mesotherapy formulations, platelet-rich plasma, iPRF, corticosteroids, and lidocaine, according to the company.
Photo caption: MicronJet 600 and 800
Photo credit: NanoPass Technologies Ltd
